Abstract | HISTORY: INVESTIGATIONS: DIAGNOSIS AND TREATMENT: CONCLUSION: XLSA is a rare differential diagnosis of acquired forms of sideroblastic anemias. A high degree of clinical suspicion is necessary for diagnosis because morphological studies such as histology and cytology may not yield conclusive results. A correct diagnosis is especially important because of the uncomplicated therapeutic options.
|
Authors | T Heller, V Höchstetter, M Basler, V Borck |
Journal | Deutsche medizinische Wochenschrift (1946)
(Dtsch Med Wochenschr)
Vol. 129
Issue 4
Pg. 141-4
(Jan 23 2004)
ISSN: 0012-0472 [Print] Germany |
Vernacular Title | Vitamin-B6-sensible hereditäre sideroblastische Anämie. |
PMID | 14724775
(Publication Type: Case Reports, English Abstract, Journal Article)
|
Chemical References |
- Hemoglobins
- Iron Chelating Agents
- Vitamin B 6
- Ferritins
- Deferoxamine
|
Topics |
- Administration, Oral
- Adult
- Anemia, Sideroblastic
(diagnosis, drug therapy, genetics)
- Bone Marrow
(pathology)
- Deferoxamine
(therapeutic use)
- Diagnosis, Differential
- Ferritins
(blood)
- Genetic Diseases, X-Linked
(diagnosis, drug therapy, genetics)
- Hematologic Tests
- Hemoglobins
(analysis)
- Humans
- Iron Chelating Agents
(therapeutic use)
- Liver
(pathology)
- Male
- Pedigree
- Vitamin B 6
(administration & dosage, therapeutic use)
|